Glaucoma Trends in glaucoma drug prescriptions: U.S. ophthalmologists favor generics and newer agents
Diabetic Macular Edema EyePoint reports favorable 6-month results for Duravyu in Phase 2 trial for DME
Glaucoma Phase 2 trials of QLS-111 meet endpoints, showing promise for glaucoma and ocular hypertension treatment
Diabetic Macular Edema FDA approves Susvimo as first continuous delivery treatment for diabetic macular edema